Management of acute decompensated heart failure: Treatment, controversy, and future directions

被引：5
作者：
Munger, Mark A.
机构：
[1] Univ Utah, Coll Pharm, Dept Pharmacotherapy, Salt Lake City, UT 84112 USA
[2] Univ Utah, Coll Med, Dept Internal Med, Salt Lake City, UT 84112 USA
来源：
PHARMACOTHERAPY | 2006年 / 26卷 / 08期
关键词：
acute decompensated heart failure; renin-angiotensin-aldosterone system; sympathetic nervous system; diuretic; inotrope; vasodilator; natriuretic peptide;
D O I：
10.1592/phco.26.8part2.131S
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Acute decompensated heart failure is a growing public health care problem worldwide. The goals of treatment are immediate hemodynamic and symptomatic improvement followed by persistent follow-up with adherence to chronic heart failure guidelines. Controversies have centered around the best treatment options and avoidance of serious adverse events. This article highlights our current understanding of acute decompensated heart failure, discusses the controversy surrounding currently available new vasoactive treatments, and details future potential therapies.
引用
收藏
页码：131S / 138S
页数：8
相关论文
共 62 条
[1]  
Abraham W T, 1998, J Card Fail, V4, P37, DOI 10.1016/S1071-9164(98)90506-1
[2]   In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications - An analysis from the Acute Decompensated Heart Failure National Registry (ADHERE) [J].
Abraham, WT ;
Adams, KF ;
Fonarow, GC ;
Costanzo, MR ;
Berkowitz, RL ;
LeJemtel, TH ;
Cheng, ML ;
Wynne, J .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (01) :57-64
[3]  
ABRAHAM WT, 2005, CIRCULATION S2, V112, P676
[4]   Characteristics and outcomes of patients hospitalized for heart failure in the United States: Rationale, design, and preliminary observations from the first 100,000, cases in the Acute Decompensated Heart Failure National Registry (ADHERE) [J].
Adams, KF ;
Fonarow, GC ;
Emerman, CL ;
LeJemtel, TH ;
Costanzo, MR ;
Abraham, WT ;
Berkowitz, RL ;
Galvao, M ;
Horton, DP .
AMERICAN HEART JOURNAL, 2005, 149 (02) :209-216
[5]   Clinical definition and epidemiology of advanced heart failure [J].
Adams, KF ;
Zannad, F .
AMERICAN HEART JOURNAL, 1998, 135 (06) :S204-S215
[6]   Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine - Is this a cause for concern? [J].
Bakris, GL ;
Weir, MR .
ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (05) :685-693
[7]   Economics of chronic heart failure [J].
Berry, C ;
Murdoch, DR ;
McMurray, JJV .
EUROPEAN JOURNAL OF HEART FAILURE, 2001, 3 (03) :283-291
[8]   Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: The PRECEDENT study [J].
Burger, AJ ;
Horton, DP ;
LeJemtel, T ;
Ghali, JK ;
Torre, G ;
Dennish, G ;
Koren, M ;
Dinerman, J ;
Silver, M ;
Cheng, ML ;
Elkayam, U .
AMERICAN HEART JOURNAL, 2002, 144 (06) :1102-1108
[9]   Comparison of the occurrence of ventricular arrhythmias in patients with acutely decompensated congestive heart failure receiving dobutamine versus nesiritide therapy [J].
Burger, AJ ;
Elkayam, U ;
Neibaur, MT ;
Haught, H ;
Ghali, J ;
Horton, DP ;
Aronson, D .
AMERICAN JOURNAL OF CARDIOLOGY, 2001, 88 (01) :35-39
[10]   BRAIN NATRIURETIC PEPTIDE - EFFECT ON LEFT-VENTRICULAR FILLING PATTERNS IN HEALTHY-SUBJECTS [J].
CLARKSON, PBM ;
WHEELDON, NM ;
MACLEOD, C ;
COUTIE, W ;
MACDONALD, TM .
CLINICAL SCIENCE, 1995, 88 (02) :159-164
1234567